Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$13.35 USD
+0.19 (1.44%)
Updated May 31, 2024 04:00 PM ET
After-Market: $13.35 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.35 USD
+0.19 (1.44%)
Updated May 31, 2024 04:00 PM ET
After-Market: $13.35 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Zacks News
Nu Skin (NUS) Looks Radiant on Innovation & Solid Digital Efforts
by Zacks Equity Research
Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.
Solid Online Sales Aid Helen of Troy (HELE), Soft Margin a Woe
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from solid online operations and Leadership Brands. However, drab operating margin is a headwind.
Nu Skin (NUS) More Than Doubles in a Year: Innovation a Driver
by Zacks Equity Research
Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.
Nu Skin (NUS) Down 3.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Helen of Troy (HELE) Poised on Leadership Brands, Online Growth
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, it is likely to keep gaining from consistent online sales.
Nu Skin (NUS) More Than Double in a Year: Will Momentum Stay?
by Zacks Equity Research
Nu Skin (NUS) is benefiting from initiatives to strengthen sales leader and expand customer base. Also, the company's focus on digital operations is impressive.
The Estee Lauder (EL) to Raise Stake in DECIEM to Aid Growth
by Zacks Equity Research
The Estee Lauder (EL) will increase its stake in DECIEM from nearly 29% to roughly 76% for almost $1 billion. The deal is likely to be concluded during the quarter ending Jun 30.
4 Factors That Make The Estee Lauder (EL) a Promising Pick
by Zacks Equity Research
The Estee Lauder's (EL) impressive online business is driving growth. Also, the company's Skin Care portfolio is performing well.
Newell Brands (NWL) Beats Q4 Earnings & Sales Estimates
by Zacks Equity Research
Despite COVID-related woes, robust consumption patterns and higher demand for certain categories aided Newell Brands' (NWL) Q4 results.
Nu Skin (NUS) Tops Q4 Earnings Estimates, Raises Dividend
by Zacks Equity Research
Growth in sales leaders and customer base drove Nu Skin's (NUS) fourth-quarter 2020 results. Notably, earnings and revenues increased year over year.
Coty (COTY) Stock Slips 15% Despite Q2 Earnings & Sales Beat
by Vrishali Bagree
Coty's (COTY) second-quarter fiscal 2021 results reflect lower earnings and sales due to the pandemic-related woes, especially in travel retail. However, e-commerce strength and cost-saving efforts aid.
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Estee Lauder (EL) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2021 sales and earnings increase year over year. However, results reflect impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Clorox (CLX) Q2 Earnings, Sales Top Estimates on Strong Demand
by Zacks Equity Research
Clorox's (CLX) Q2 sales benefit from double-digit sales growth in the majority of the segments, fueled by strong product demand due to the coronavirus outbreak and related shift in trends.
Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty
Inter Parfums (IPAR) Ups 2020 Earnings View on Solid Q4 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2020. Management raises 2020 earnings guidance.
5 Cosmetics Stocks Looking Good Amid Industry Challenges
by Vrishali Bagree
The Zacks Cosmetics industry is battling coronavirus woes like weak travel retail, reduced traffic and low makeup demand. However, high demand for personal care products bodes well for EL, HELE, COTY, NUS and ELF, which are focused on adapting to the changing market trends.
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Procter & Gamble (PG) Q2 Earnings & Sales Beat, FY21 View Up
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results gain from solid performance across all segments as well as a rise in organic shipment volumes, improved pricing and mix. Encouragingly, it lifts fiscal 2021 view.
3 Factors That Makes Helen of Troy (HELE) a Promising Pick
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, strength in the company's online business is yielding.
Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Nu Skin (NUS) Looks Buoyant, Stock Up More Than 35% in a Year
by Zacks Equity Research
Nu Skin (NUS) has been benefiting from focus on innovation as well as commitment to strengthening sales leaders.